BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Uchida H, Ohishi H, Matsuo N, Nishimine K, Ohue S, Nishimura Y, Maeda M, Yoshioka T. Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and Gelfoam particles for hepatocellular carcinoma. Cardiovasc Intervent Radiol. 1990;13:140-145. [PMID: 2171772 DOI: 10.1007/bf02575465] [Cited by in Crossref: 141] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Nishimine K, Uchida H, Matsuo N, Sakaguchi H, Hirohashi S, Nishimura Y, Guo Q, Ohishi H, Nagano N, Yoshioka T. Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results. Cancer Chemother Pharmacol. 1994;33 Suppl:S60-S68. [PMID: 7511069 DOI: 10.1007/bf00686670] [Cited by in Crossref: 47] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
2 Bannangkoon K, Hongsakul K, Tubtawee T, Piratvisuth T. Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization. Clin Mol Hepatol 2019;25:74-85. [PMID: 30813680 DOI: 10.3350/cmh.2018.0072] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
3 Miyayama S, Yamashiro M, Shibata Y, Hashimoto M, Yoshida M, Tsuji K, Toshima F, Matsui O. Comparison of local control effects of superselective transcatheter arterial chemoembolization using epirubicin plus mitomycin C and miriplatin for hepatocellular carcinoma. Jpn J Radiol. 2012;30:263-270. [PMID: 22223074 DOI: 10.1007/s11604-011-0043-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
4 Kasai K, Ushio A, Kasai Y, Sawara K, Miyamoto Y, Oikawa K, Takikawa Y, Suzuki K. Therapeutic efficacy of transarterial chemo-embolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma. World J Gastroenterol. 2013;19:2242-2248. [PMID: 23599651 DOI: 10.3748/wjg.v19.i14.2242] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
5 Park SH, Cho YK, Ahn YS, Park YO, Kim JK, Chung JW. Local recurrence of hepatocellular carcinoma after segmental transarterial chemoembolization: risk estimates based on multiple prognostic factors. Korean J Radiol 2007;8:111-9. [PMID: 17420628 DOI: 10.3348/kjr.2007.8.2.111] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
6 Lanza E, Donadon M, Poretti D, Pedicini V, Tramarin M, Roncalli M, Rhee H, Park YN, Torzilli G. Transarterial Therapies for Hepatocellular Carcinoma. Liver Cancer 2016;6:27-33. [PMID: 27995085 DOI: 10.1159/000449347] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]
7 Nakai M, Sato M, Sahara S, Kawai N, Tanihata H, Kimura M, Terada M. Radiofrequency ablation in a porcine liver model: effects of transcatheter arterial embolization with iodized oil on ablation time, maximum output, and coagulation diameter as well as angiographic characteristics. World J Gastroenterol 2007;13:2841-5. [PMID: 17569120 DOI: 10.3748/wjg.v13.i20.2841] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
8 Shimohira M, Ogino H, Kawai T, Kushita A, Watanabe M, Kawaguchi T, Kurono K, Shibamoto Y. Use of the triaxial microcatheter method in super-selective transcatheter arterial chemoembolisation for hepatocellular carcinoma. Br J Radiol 2011;84:184-7. [PMID: 21257838 DOI: 10.1259/bjr/26974088] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
9 Miyayama S, Yamakado K, Anai H, Abo D, Minami T, Takaki H, Kodama T, Yamanaka T, Nishiofuku H, Morimoto K, Soyama T, Hasegawa Y, Nakamura K, Yamanishi T, Sato M, Nakajima Y. Guidelines on the use of gelatin sponge particles in embolotherapy. Jpn J Radiol 2014;32:242-50. [PMID: 24510242 DOI: 10.1007/s11604-014-0292-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 4.1] [Reference Citation Analysis]
10 Zhang JW, Feng XY, Liu HQ, Yao ZW, Yang YM, Liu B, Yu YQ. CT volume measurement for prognostic evaluation of unresectable hepatocellular carcinoma after TACE. World J Gastroenterol. 2010;16:2038-2045. [PMID: 20419843 DOI: 10.3748/wjg.v16.i16.2038] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
11 Katsumori T, Fujita M, Takahashi T, Satoh O, Ichijima S, Nakamura T, Morishita H, Ohno K, Nakano Y, Maeda T. Effective segmental chemoembolization of advanced hepatocellular carcinoma with tumor thrombus in the portal vein. Cardiovasc Intervent Radiol. 1995;18:217-221. [PMID: 8581900 DOI: 10.1007/bf00239415] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
12 Cho YK, Chung JW, Ahn YS, Park YO, Kim JK, Byun JH. Risk factors for local tumor recurrence after segmental transarterial chemoembolization for hepatocellular carcinoma: the importance of tumor located in the segmental border zone. Korean J Radiol 2006;7:267-74. [PMID: 17143030 DOI: 10.3348/kjr.2006.7.4.267] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
13 Osuga K, Maeda N, Higashihara H, Hori S, Nakazawa T, Tanaka K, Nakamura M, Kishimoto K, Ono Y, Tomiyama N. Current status of embolic agents for liver tumor embolization. Int J Clin Oncol 2012;17:306-15. [PMID: 22806426 DOI: 10.1007/s10147-012-0445-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
14 Sakaguchi H, Uchida H, Maeda M, Matsuo N, Kichikawa K, Ohishi H, Nishida H, Ueno K, Nishimine K, Rösch J, Guo Q. Combined transjugular intrahepatic portosystemic shunt and segmentai lipiodol hepatic artery embolization for the treatment of esophagogastric varices and hepatocellular carcinoma in patients with cirrhosis: Preliminary report. Cardiovasc Intervent Radiol 1995;18:9-15. [DOI: 10.1007/bf02807348] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
15 Imai N, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Hirooka Y, Goto H. Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques. World J Hepatol. 2014;6:844-850. [PMID: 25544871 DOI: 10.4254/wjh.v6.i12.844] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
16 Miraglia R, Pietrosi G, Maruzzelli L, Petridis I, Caruso S, Marrone G, Mamone G, Vizzini G, Luca A, Gridelli B. Predictive factors of tumor response to trans-catheter treatment in cirrhotic patients with hepatocellular carcinoma: a multivariate analysis of pre-treatment findings. World J Gastroenterol 2007;13:6022-6. [PMID: 18023093 DOI: 10.3748/wjg.v13.45.6022] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
17 Ishikawa T, Abe S, Hoshii A, Yamada Y, Iiduka A, Nemoto T, Takeda K, Yoshida T. Cone-Beam Computed Tomography Correlates with Conventional Helical Computed Tomography in Evaluation of Lipiodol Accumulation in HCC after Chemoembolization. PLoS One. 2016;11:e0145546. [PMID: 26752696 DOI: 10.1371/journal.pone.0145546] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
18 Uchida H, Matsuo N, Sakaguchi H, Nagano N, Nishimine K, Ohishi H. Segmental embolotherapy for hepatic cancer: keys to success. Cardiovasc Intervent Radiol. 1993;16:67-71. [PMID: 8387393 DOI: 10.1007/bf02602980] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
19 Ji SK, Cho YK, Ahn YS, Kim MY, Park YO, Kim JK, Kim WT. Multivariate analysis of the predictors of survival for patients with hepatocellular carcinoma undergoing transarterial chemoembolization: focusing on superselective chemoembolization. Korean J Radiol. 2008;9:534-540. [PMID: 19039270 DOI: 10.3348/kjr.2008.9.6.534] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
20 Kwak K, Yu B, Mouli SK, Larson AC, Kim DH. Sodium Cholate Bile Acid-Stabilized Ferumoxytol-Doxorubicin-Lipiodol Emulsion for Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma. J Vasc Interv Radiol 2020;31:1697-1705.e3. [PMID: 32773247 DOI: 10.1016/j.jvir.2020.01.026] [Reference Citation Analysis]
21 Miraglia R, Pietrosi G, Maruzzelli L, Petridis I, Caruso S, Marrone G, Mamone G, Vizzini G, Luca A, Gridelli B. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma. World J Gastroenterol 2007;13:2952-5. [PMID: 17589945 DOI: 10.3748/wjg.v13.i21.2952] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
22 Miyayama S, Matsui O, Yamashiro M, Ryu Y, Takata H, Takeda T, Aburano H, Shigenari N. Iodized oil accumulation in the hypovascular tumor portion of early-stage hepatocellular carcinoma after ultraselective transcatheter arterial chemoembolization. Hepatol Int. 2007;1:451-459. [PMID: 19669342 DOI: 10.1007/s12072-007-9030-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
23 Sung YM, Choi D, Lim HK, Lee WJ, Kim SH, Kim MJ, Paik SW, Yoo BC, Koh KC, Lee JH, Choi MS. Long-term results of percutaneous ethanol injection for the treatment of hepatocellular carcinoma in Korea. Korean J Radiol 2006;7:187-92. [PMID: 16969048 DOI: 10.3348/kjr.2006.7.3.187] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
24 Matsui O, Kadoya M, Yoshikawa J, Gabata T, Takashima T, Demachi H. Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas: local therapeutic effect and 5-year survival rate. Cancer Chemother Pharmacol. 1994;33 Suppl:S84-S88. [PMID: 8137490 DOI: 10.1007/bf00686674] [Cited by in Crossref: 50] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
25 Tsurusaki M, Murakami T. Surgical and Locoregional Therapy of HCC: TACE. Liver Cancer 2015;4:165-75. [PMID: 26675172 DOI: 10.1159/000367739] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 8.2] [Reference Citation Analysis]
26 Li X, Hu G, Liu P. Segmental embolization by ethanol iodized oil emulsion for hepatocellular carcinoma. J Tongji Med Univ. 1999;19:135-140. [PMID: 12840858 DOI: 10.1007/bf02886895] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
27 Maeda N, Osuga K, Mikami K, Higashihara H, Onishi H, Nakaya Y, Tatsumi M, Hori M, Kim T, Tomoda K, Nakamura H. Angiographic evaluation of hepatic arterial damage after transarterial chemoembolization for hepatocellular carcinoma. Radiat Med 2008;26:206-12. [DOI: 10.1007/s11604-007-0216-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
28 Wang JH, Lin G, Yan ZP, Wang XL, Cheng JM, Li MQ. Stage II surgical resection of hepatocellular carcinoma after TAE:a report of 38 cases. World J Gastroenterol 1998;4:133-6. [PMID: 11819256 DOI: 10.3748/wjg.v4.i2.133] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
29 Nakao N, Uchida H, Kamino K, Nishimura Y, Ohishi H, Takayasu Y, Miura K. Determination of the optimum dose level of lipiodol in transcatheter arterial embolization of primary hepatocellular carcinoma based on retrospective multivariate analysis. Cardiovasc Intervent Radiol. 1994;17:76-80. [PMID: 8013027 DOI: 10.1007/bf00193921] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
30 Chung J, Yu JS, Chung JJ, Kim JH, Kim KW. Haemodynamic events and localised parenchymal changes following transcatheter arterial chemoembolisation for hepatic malignancy: interpretation of imaging findings. Br J Radiol. 2010;83:71-81. [PMID: 19581309 DOI: 10.1259/bjr/82377365] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]